TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Nipro ( (JP:8086) ).
Nipro Corporation reported its consolidated financial results for the three months ended June 30, 2025, showing a 4.5% increase in net sales and a 24.6% rise in operating profit compared to the previous year. Despite these gains, the company experienced a significant decline in ordinary profit by 45.2%, reflecting challenges in its operations. The financial forecast for the fiscal year ending March 31, 2026, anticipates continued growth in net sales and operating profit, indicating a positive outlook for stakeholders.
The most recent analyst rating on (JP:8086) stock is a Buy with a Yen1600.00 price target. To see the full list of analyst forecasts on Nipro stock, see the JP:8086 Stock Forecast page.
More about Nipro
Nipro Corporation is a company listed on the Tokyo Stock Exchange, operating in the healthcare industry. It specializes in manufacturing and distributing medical devices, pharmaceutical products, and glass products, focusing on improving patient care and medical outcomes.
Average Trading Volume: 539,690
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen226.5B
See more insights into 8086 stock on TipRanks’ Stock Analysis page.